Crosseal Market Report 2026

Crosseal Market Overview

• The Crosseal market growth in the historic period has been driven by clinical validation of fibrin sealants, rising surgical procedure volumes • Market expansion is supported by growth in orthopedic and cardiac surgeries, expansion of outpatient surgical centers • Growth Driver: Rising Injury Rates Drive Growth In The Market • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Crosseal Market?

Crosseal is a brand name for a fibrin sealant. Fibrin sealants are biological adhesives used to stop bleeding (hemostasis) and promote tissue healing in surgical procedures. They are made from fibrinogen and thrombin, which, when combined, mimic the final steps of the natural blood clotting process, forming a clot to seal tissue and stop bleeding. The main types of crosseal are fibrin sealants, synthetic sealants, and hemostatic agents. Fibrin sealants are biological adhesives made from fibrinogen and thrombin, which are components of blood that help promote clotting. The various surgeries include orthopedic surgeries, cardiac surgeries, general surgeries, liver surgeries, and gynecological surgeries. These are distributed through various distribution channels such as hospital pharmacies, surgical supply distributors, and outpatient surgery centers.

What Is The Crosseal Market Growth Forecast?

The growth in the forecast period can be attributed to growth in orthopedic and cardiac surgeries, expansion of outpatient surgical centers, rising preference for biologic sealants, technological advances in tissue adhesives, aging population requiring surgeries. Major trends in the forecast period include increasing use of fibrin sealants in surgery, growing focus on surgical hemostasis, expansion of minimally invasive surgical procedures, rising adoption of biological tissue adhesives, improved outcomes in complex surgical interventions.

Global Crosseal Market Segmentation

1) By Product Type: Fibrin Sealants, Synthetic Sealants, Hemostatic Agents 2) By Type Of Surgery: Orthopedic Surgeries, Cardiac Surgeries, General Surgeries, Liver Surgeries, Gynecological Surgeries 3) By Distribution Channel: Hospital Pharmacies, Surgical Supply Distributors, Outpatient Surgery Centers

What Are The Drivers Of The Crosseal Market?

The increasing number of injuries is expected to boost the growth of the crosseal market going forward. Injuries are physical harm or damage to the body caused by external force, trauma, or adverse conditions such as accidents, falls, or violence. The increasing number of injuries is due to factors such as urbanization, increased road traffic, unsafe work environments, lifestyle changes, and rising occurrences of violence and natural disasters. Crosseal helps patients with injuries by providing advanced tissue-sealing solutions that promote rapid hemostasis, reduce surgical complications, and support faster recovery, enhancing overall treatment outcomes. For instance, in May 2025, according to Transport Canada, a Canada-based government agency, in 2023, motor vehicle fatalities reached 1,964, marking a 1.7% increase from the 1,931 deaths reported in 2022. Therefore, the increasing number of injuries is driving the growth of the crosseal industry. The increasing number of minimally invasive surgeries is expected to propel the growth of the crosseal market going forward. Minimally invasive surgeries (MIS) are medical procedures performed through tiny incisions or natural body openings, using specialized instruments and techniques that minimize damage to surrounding tissues. The growing prevalence of minimally invasive surgeries is driven by advancements in medical technology and a rising patient preference for procedures that offer shorter recovery times and reduced post-operative pain. Crosseal enhances minimally invasive procedures by providing efficient hemostasis, reducing bleeding risks, and promoting faster healing, thereby ensuring improved patient outcomes and streamlined surgical processes. For instance, in 2023, according to the American Society of Plastic Surgeons, a US-based specialty organization, the total number of cosmetic minimally invasive procedures increased from 23.7 million in 2022 to 25.4 million in 2023. Therefore, the increasing number of minimally invasive surgeries is driving the growth of the crosseal industry. The rise in healthcare spending is expected to accelerate the growth of the crosseal market going forward. Healthcare spending refers to the total expenditure on health services and products, including medical care, hospital services, preventive care, medications, research, infrastructure, and administrative costs, aimed at maintaining or improving the health and well-being of individuals and populations. The rise in healthcare spending is attributed to an aging population, advancements in medical technology, rising prevalence of chronic diseases, and increased demand for healthcare services. Healthcare spending supports crosseal, as increased investments in medical advancements and surgical procedures highlight the need for effective hemostatic agents to enhance patient outcomes and support efficient healthcare delivery. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in the UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, the rise in healthcare spending is driving the growth of the crosseal industry.

Key Players In The Global Crosseal Market

Major companies operating in the crosseal market are Omrix Biopharmaceuticals Inc.

Regional Insights

North America was the largest region in the crosseal market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Crosseal Market?

The crosseal market consists of sales of tissue sealants and biological glues. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Crosseal Market Report 2026?

The crosseal market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the crosseal industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.